Jun 30, 2018

Xenon Pharmaceuticals Q2 2018 Earnings Report

EPS
-$0.45
Previous year: -$0.41
+9.8%
Cash and Equivalents
$47.4M
Previous year: $23.1M
+105.4%
Free Cash Flow
-$5.68M
Previous year: -$13.4M
-57.5%
Total Assets
$65.4M
Previous year: $54.2M
+20.7%

Xenon Pharmaceuticals

Xenon Pharmaceuticals